Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC (non-small Cell Lung Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05730972
What this trial is testing

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Who this might be right for
Cancer PainNon Small Cell Lung CancerBone Metastases+1 more
The Third Affiliated hospital of Zhejiang Chinese Medical University 188
Not applicableNot Yet RecruitingNCT07179445
What this trial is testing

Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 300
Early research (Phase 1)WithdrawnNCT07073183
What this trial is testing

Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)

Who this might be right for
Squamous NSCLC
CureVac
Testing effectiveness (Phase 2)UnknownNCT04989322
What this trial is testing

Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC

Who this might be right for
NsclcEGFR Activating MutationEGF-R Positive Non-Small Cell Lung Cancer+3 more
Dr Joanne CHIU 46
Not applicableStudy completedNCT05321212
What this trial is testing

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

Who this might be right for
Carcinoma, Non-Small-Cell LungImmunotherapy
University Hospital, Brest 108
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Not applicableStudy completedNCT04640870
What this trial is testing

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Who this might be right for
Non Small Cell Lung CancerEGF-R Positive Non-Small Cell Lung CancerEGFR Gene Mutation
Hellenic Cooperative Oncology Group 59
Early research (Phase 1)Looking for participantsNCT06813365
What this trial is testing

Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)

Who this might be right for
Nonsmall-cell Lung Cancer
Dizal Pharmaceuticals 300
Testing effectiveness (Phase 2)UnknownNCT03612154
What this trial is testing

Study of Lorlatinib in ROS1 Rearranged NSCLC

Who this might be right for
Nonsmall Cell Lung Cancer
National Cancer Center, Korea 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888831
What this trial is testing

BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Testing effectiveness (Phase 2)UnknownNCT03119519
What this trial is testing

Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Southern Medical University, China 148
Early research (Phase 1)UnknownNCT05580172
What this trial is testing

Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Safety Issues
ReHeva Biosciences,Inc. 6
Not applicableActive Not RecruitingNCT01888601
What this trial is testing

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

Who this might be right for
Non-small Cell Lung Cancer
University College, London 814
Testing effectiveness (Phase 2)Study completedNCT03129256
What this trial is testing

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University 52
Testing effectiveness (Phase 2)Study completedNCT01048645
What this trial is testing

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Institute of Cancerología 107
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Not applicableStudy completedNCT04667312
What this trial is testing

Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
AstraZeneca 115
Large-scale testing (Phase 3)Looking for participantsNCT07182682
What this trial is testing

Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

Who this might be right for
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 360
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Next Page